Peak VO2 maintained in HF patients on IV iron therapy - PACE-CME

Peak VO maintained in HF patients on IV iron therapy

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Beneficial effects of MRAs in HF across the LVEF spectrum
Beneficial effects of MRAs in HF across the LVEF spectrum
ESC Congress 2024
Beneficial effects of MRAs in HF across the LVEF spectrum
- Pardeep Jhund, MD, PhD
Disease-modifying effects of finerenone in CKM syndrome
Disease-modifying effects of finerenone in CKM syndrome
ESC Congress 2024
Disease-modifying effects of finerenone in CKM syndrome
- Muthiah Vaduganathan, MD
Remarkable results in phase 3 study with vutrisiran in patients with ATTR-CM
Remarkable results in phase 3 study with vutrisiran in patients with ATTR-CM
ESC Congress 2024
Remarkable results in phase 3 study with vutrisiran in patients with ATTR-CM
- Marianna Fontana, MD, PhD
Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy
Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy
MinuteCE®
Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy
0.75 program credits
- Gianluigi Savarese, MD
0.75 program credits